There's also lots of news to share about MS disease-modifying therapies including the availability of a newly-approved DMT, an extended FDA review of a potential DMT that was expected to be approved this month, encouraging news about yet another potential DMT that's currently in development, and a change in an already-approved DMT.
We have a lot to talk about! Are you ready for RealTalk MS??!
An important message from National MS Society President & CEO, Cyndi Zagieboylo :21
Did you catch our special bonus episode recapping the Consortium of MS Centers Annual Meeting? 2:32
Zeposia, a new MS disease-modifying therapy is now available in the U.S. 4:33
FDA Extends its review of Ofatumumab 5:51
EMD Serono Shares Encouraging Data from its Phase 2 Clinical Trial of Evobrutinib 6:59
EMA Approves Shorter Infusion Time for Ocrevus 7:52
My Interview with Dr. Jennifer Graves 9:07
Share this episode 25:26
Please Support the National MS Society COVID-19 Response Fund 25:50
SHARE THIS EPISODE OF REALTALK MS
Just copy this link & paste it into your text or email: https://realtalkms.com/145
ADD YOUR VOICE TO THE CONVERSATION
I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!
Phone: (310) 526-2283
And don't forget to join us in the RealTalk MS Facebook group!
RealTalk MS Episode 145
Hosted By: Jon Strum
Guests: Dr. Jennifer Graves
Tags: MS, MultipleSclerosis, MSResearch, MSSociety, RealTalkMS